Montreal Heart Institute reports positive results from Covid-19 trial
The Montreal Heart Institute (MHI) has announced positive, clinically persuasive results from the COLCORONA clinical...
SaNOtize initiates trials of nasal spray against Covid-19 in UK
Canada-based SaNOtize Research and Development has initiated the clinical trials of its nasal spray against...
HLS Therapeutics reports positive data from Covid-19 outpatient trial
HLS Therapeutics has announced that clinical results from the CardioLink-9 Trial showed Vascepa (icosapent ethyl)...
Cabenuva (cabotegravir and rilpivirine) for the Treatment of HIV-1 Infection
Cabenuva is a complete antiretroviral regimen comprising Vocabria (cabotegravir) and Edurant (rilpivirine) for the treatment...
MHI continues recruitment of non-hospitalised participants in Covid-19 trial
The Montreal Heart Institute (MHI) is continuing the COLCORONA clinical trial to recruit non-hospitalised adult...
Medicago reports interim results of Phase I trial of Covid-19 vaccine
Biopharmaceutical company Medicago has reported interim results of the Phase I clinical trial of the...
Aurinia initiates voclosporin trial in KTRs with Covid-19
Aurinia Pharmaceuticals has initiated an open-label exploratory trial to analyse the antiviral effects of voclosporin...
Appili Therapeutics doses first patients in Covid-19 clinical trial
Canada-based Appili Therapeutics has enrolled and dosed the first cluster of participants in its Phase...
MediPharm begins trial of cannabis-derived products for kidney disease
Canada-based MediPharm Labs has begun a clinical trial to research and analyse the effectiveness of...
Revive Therapeutics expands Phase III Covid-19 trial of Bucillamine
Revive Therapeutics is set to expand the Phase III clinical trial of Bucillamine as a...